Members’ Labs

Marlene Rabinovitch, M.D. June 1, 2020 Dwight and Vera Dunlevie Professor of Pediatrics (Cardiology) Stanford University School of Medicine Stanford, CA Primary Research: Our research program seeks to identify the cellular and molecular programs that are dysregulated in vascular disease with a focus on pulmonary arterial hypertension (PAH). This condition can be a fatal complication…

Julie A. Phillippi, Ph.D. May 1, 2020 Department of Cardiothoracic Surgery and McGowan Institute for Regenerative Medicine University of Pittsbugh Pittsburgh, PA Primary Research: The Phillippi Laboratory is focused on two primary objectives 1) Understanding the role of the microvasculature in cardiovascular pathologies; and 2) Developing novel technologies that therapeutically preserve or regenerate microvasculature. Active…

Angela Glading, Ph.D. April 1, 2020 Department of Pharmacology and Physiology University of Rochester Rochester, NY Primary Research: Defective or improperly regulated adhesion is observed in a wide variety of human diseases, including the major killers cancer and cardiovascular disease. Research in the Glading lab focuses on unraveling how cell adhesion signaling regulates cellular behavior,…

Amber Stratman, Ph.D. March 1, 2020 Department of Cell Biology and Physiology Washington University School of Medicine St. Louis, MO Primary Research: My research group is interested in the mechanosensitive inputs that direct mural cell recruitment to arteries during development. We are particularly interested in how mechanosensitive proteins couple force inputs from a 3D environment…

Roger Johns, M.D., Ph.D. February 1, 2020 Department of Anesthesiology and Critical Care Medicine Johns Hopkins University Baltimore, MD Primary Research: We discovered hypoxia-induced mitogenic factor (HIMF) as an unknown gene in lung from a hypoxia model of pulmonary hypertension. This was subsequently found to be a member of the resistin-like family of chemokine growth…

Sara S. Nunes de Vasconcelos, Ph.D. January 1, 2020 Division of Experimental Therapeutics Toronto General Hopistal Research Institute and University of Toronto Toronto, Ontario Canada Primary Research: Motivated by the need to generate alternative therapeutic avenues to treat cardiovascular diseases, my research interests involve the development of vascularization strategies in combination with human stem cell-derived…

Monica Hinds, Ph.D. October 1, 2019 Department of Biomedical Engineering Oregon Health & Science University Portland, OR Primary Research:   The goal of our research is to determine the molecular responses of blood and vascular cells in cardiovascular disease to biomaterial surfaces and use this knowledge to design new materials for cardiovascular applications. In our research…

Patrick A. Murphy, Ph.D. September 1, 2019 Department of Cell Biology Center for Vascular Biology and Calhoun Cardiology Center University of Connecticut Health Center Farmington, CT Primary Research: Dr. Murphy’s lab studies the post-transcriptional life of RNA, in alternative splicing, stability and localization. He is interested in the regulation of these functions by RNA-binding proteins…

Ngan F. Huang, Ph.D. July 1, 2019 Department of Cardiothoracic Surgery Principal Investigator, Veterans Affairs Palo Alto Health Care System Stanford University Stanford, CA Primary Research: Dr. Huang’s laboratory investigates the interactions between stem cells and the extracellular matrix microenvironment for engineering cardiovascular tissues to treat cardiovascular diseases such as peripheral arterial disease and abdominal…

Delphine Gomez, Ph.D. May 1, 2019 Department of Medicine Division of Cardiology University of Pittsburgh Pittsburgh, PA Primary Research: The Gomez lab is focused on studying the functional role of epigenetic and transcriptional mechanisms in controlling key properties of vascular smooth muscle cells (SMC) including cell differentiation, lineage memory and plasticity in the context of…